6/22/2010
Ensemble Evolves Name to Ensemble Therapeutics Corporation and Also Announces New Strategic Investor: Kisco Ltd.
1/6/2010
Ensemble Discovery's CEO, Dr. Mike Taylor, discussing Pfizer alliance on NECN
Ensemble Discovery Initiates Collaboration with Pfizer to Develop Novel Drugs Against Protein-Protein Interaction Targets
9/7/2009
Ensemble Discovery Highlighted in "Big Hopes Ride on Big Rings" Chemical & Engineering News, September 7, 2009, 87 (36), pg. 54 - 57
4/15/2009
Ensemble Discovery Initiates Collaboration with Bristol-Myers Squibb to Develop Drugs in Novel Therapeutic Class
11/13/2008
Ensemble Discovery and Roche Initiate Product Development Program to Advance New Diagnostic Technology to Optimize Cancer Therapy
4/16/2008
Ensemble Discovery received the Outstanding Poster Presentation Award at the 40th Oak Ridge Conference, Breakthrough Technologies for Clinical Diagnostics, "DNA-Programmed Chemistry for the Detection of BCR-ABL Fusion Protein in Expressing Cells". (PDF 3.1 MB)
4/1/2008
Ensemble Featured in BioIT World Article - Breaking the Rule (of Five), Kevin Davies
2008
Written by E.M. Driggers, S.P. Hale, J. Lee and N.K. Terrett "Macrocycles for Drug Discovery – An Underexploited Structural Class" Nature Reviews Drug Discovery, 2008, 7, pp 608-624.
Written by Yumei Huang and James M. Coull "Diamine Catalyzed Hemicyanine Dye Formation from Nonfluorescent Precursors through DNA Programmed Chemistry" J. Am. Chem. Soc., 2008, 130 (11), pp 3238-3239
[ back to top ]
